Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,096.00
Bid: 12,094.00
Ask: 12,098.00
Change: 46.00 (0.38%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: ARM Leads Rising Market But Tour Operators Down

Mon, 18th Jul 2016 07:32

LONDON (Alliance News) - Stocks in London were higher shortly after the open Monday, with ARM Holdings shares rocketing to the top of the FTSE 100 after the company confirmed it has agreed to be acquired by SoftBank Group for GBP24.3 billion.

The FTSE 100 was up 0.7%, or 43.20 points at 6,713.14. The FTSE 250 was 1.0% higher at 16,894.26, while the AIM All-Share was adding 0.2% at 725.49.

Shares in ARM were up 45% at 1,729.00 pence. The FTSE 100-listed group, which makes chips used in smartphones and other connected devices, said Japanese technology and telecommunications conglomerate SoftBank will pay 1,700.00p per share.

That represents a 43% premium to ARM's closing price on Friday of 1,188.73p and a 42% premium to the all-time high that ARM shares hit in March 2015. The agreement earlier had been reported by the Financial Times newspaper.

SoftBank said is intends to maintain ARM's existing management team and brand and will maintain the company's headquarters in Cambridge. It plans to at least double ARM's UK headcount over the next five years and will boost the group's employee numbers internationally too. ARM's board said it unanimously recommends the offer.

Accendo Markets analyst Michael van Dulken said the positive open comes after the Turkish government took back control after a failed military coup. However, the analyst said that "this happening so soon after the tragic events in Nice last week simply adds to plentiful pre-existing geopolitical tension".

Van Dulken said investors will focus on the potential consequences the events in Turkey for both Middle East and European stability given the country's strategic geographic location.

Travel stocks were mixed. Air carriers International Consolidated Airlines Group and easyJet up 2.2% and 1.0%, respectively. However, travel operator TUI Group was down 1.6% and FTSE 250-listed Thomas Cook Group was the biggest mid-cap decliner, down 5.4%.

Shares in FTSE 100-listed AstraZeneca were up 0.6%. The drugmaker said its Tagrisso lung cancer treatment met its primary endpoint in phase 3 trials. AstraZeneca said the drug demonstrated superior progression-free survival rates in comparison to standard platinum-based doublet chemotherapy.

British Land was down 0.4%. The commercial property investor said that, while too early to assess the impact the UK's vote to leave the European Union will have on property markets in the UK, it does anticipates some extra caution from occupiers and investors.

Due to this, Liberum kept a Sell recommendation on British Land, but the broker acknowledged that it was a "robust quarter" for the real estate group.

British Land said that, in the first quarter to the end of June, it secured 256,000 square feet of retail lettings and renewals. Retail footfall in its properties was flat in the quarter, it said. Office lettings and renewals in the quarter totalled 25,000 square feet. Its said its occupancy rate is at 99% and confirmed its dividend for the first quarter of 7.30 pence per share, 3.0% higher year-on-year.

Ahead in the economic calendar on Monday, Bank of England Monetary Policy Committee member Martin Weale is due to make a speech at 0915 BST, and the Bundesbank's monthly report is at 1100 BST. Later in the day is the US National Association of Home Builders' housing market index.

Already released, the average asking price of a house in the UK was down 0.9% in July from the month before, property tracking website Rightmove said on Monday - coming in at GBP307,824. That followed a 0.8% increase in June. On a yearly basis, prices advanced 4.5%, slowing from 5.5% in the previous month.

Meanwhile, British retailers logged the steepest decline in footfall since early 2014, data published by the British Retail Consortium and Springboard showed. In June, footfall dropped 2.8% in June from last year, following a 0.3% rise in May. This was the sharpest fall since February 2014.

In Asia on Monday, the Tokyo market was closed for the Marine Day holiday. In China, the Shanghai Composite index fell 0.4%, while the Hang Seng index in Hong Kong continues up 0.7%.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.